ATE188253T1 - Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen - Google Patents

Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen

Info

Publication number
ATE188253T1
ATE188253T1 AT92924122T AT92924122T ATE188253T1 AT E188253 T1 ATE188253 T1 AT E188253T1 AT 92924122 T AT92924122 T AT 92924122T AT 92924122 T AT92924122 T AT 92924122T AT E188253 T1 ATE188253 T1 AT E188253T1
Authority
AT
Austria
Prior art keywords
collagen
collagens
synthesis
recombinant dna
human
Prior art date
Application number
AT92924122T
Other languages
English (en)
Inventor
Darwin J Prockop
Lenna Ala-Kokko
Andrzej Fertala
Aleksander Sieron
Kari I Kivirikko
Amy Geddis
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25121036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE188253(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE188253T1 publication Critical patent/ATE188253T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT92924122T 1991-10-23 1992-10-22 Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen ATE188253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78089991A 1991-10-23 1991-10-23
PCT/US1992/009061 WO1993007889A1 (en) 1991-10-23 1992-10-22 Synthesis of human procollagens and collagens in recombinant dna systems

Publications (1)

Publication Number Publication Date
ATE188253T1 true ATE188253T1 (de) 2000-01-15

Family

ID=25121036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924122T ATE188253T1 (de) 1991-10-23 1992-10-22 Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen

Country Status (11)

Country Link
US (1) US5405757A (de)
EP (2) EP0625048B2 (de)
JP (2) JP3302017B2 (de)
AT (1) ATE188253T1 (de)
AU (2) AU680606B2 (de)
CA (1) CA2121698C (de)
DE (1) DE69230502T3 (de)
DK (1) DK0625048T4 (de)
ES (1) ES2143478T5 (de)
GR (1) GR3033022T3 (de)
WO (1) WO1993007889A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
CA2152595A1 (en) * 1993-10-25 1995-05-04 Shinji Kobayashi Purified human chondrocalcin, process for producing the same, and utilization thereof
WO1995031473A1 (en) * 1994-05-11 1995-11-23 Organogenesis Inc. Collagen from cell cultures
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
BR9610070A (pt) * 1995-08-08 1999-07-27 Univ Jefferson Sequência de ácido nucleico polipetídeos compostos antifibrótico e processo para tratar distúrbios ou doenças relacionadas com fibrose para usar a sequência de dna e para produzir c-proteinase recombinante
DK0859838T3 (da) * 1995-08-31 2003-10-06 Univ Manchester Hidtil ukendte procollagener
AU7450496A (en) * 1995-10-20 1997-05-07 Collagen Corporation Production of recombinant procollagen in yeast
EP0861086A1 (de) * 1995-11-13 1998-09-02 Fibrogen, Inc. Typ ix kollagen und chimere
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
WO1997038710A1 (en) * 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
AU780813B2 (en) * 1996-10-29 2005-04-21 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
CA2269801A1 (en) * 1996-10-29 1998-05-07 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
GB9704305D0 (en) * 1997-03-01 1997-04-23 Univ Manchester Procollagen assembly
NL1007908C2 (nl) * 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
US6150081A (en) 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
DE19812713A1 (de) * 1998-03-24 1999-09-30 Merck Patent Gmbh Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff
JP2000125872A (ja) * 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
CN1285612C (zh) * 1999-11-12 2006-11-22 法布罗根股份有限公司 动物胶原和明胶
RU2002112751A (ru) * 1999-11-12 2004-02-27 Файброджен, Инк. (Us) Рекомбинантные желатины
US7491691B2 (en) 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
EP1549255A4 (de) 2002-09-13 2007-12-19 Coopervision Inc Vorrichtungen und verfahren zur verbesserung der sehstärke
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
US20050259221A1 (en) 2004-05-20 2005-11-24 Coopervision, Inc Corneal onlays and wavefront aberration correction to enhance vision
AU2012200573B2 (en) * 2005-03-31 2013-11-07 Fuso Pharmaceutical Industries, Ltd. "Process for production of protein having triple-helical structure"
ES2489715T3 (es) 2005-03-31 2014-09-02 Fuso Pharmaceutical Industries Ltd. Procedimiento para la produccíón de colágeno humano de tipo II
ES2661728T3 (es) 2005-10-03 2018-04-03 Pinksky, Mark A. Composiciones y métodos para el cuidado mejorado de la piel
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
EP2222270B1 (de) 2007-12-26 2018-11-14 Mark A. Pinsky Collagenformulierungen für verbesserte hautpflege
US9095569B2 (en) * 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
DK2380979T3 (da) 2008-12-22 2015-06-22 Univ Hokkaido Nat Univ Corp Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
KR20220062230A (ko) * 2019-05-14 2022-05-16 프로베넌스 바이오 엘엘씨 퍼옥시좀에서 변형 단백질의 발현
KR102135976B1 (ko) * 2019-10-24 2020-07-20 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 펩타이드 및 이를 이용한 방법
DE102021202830A1 (de) 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
WO2023194333A1 (en) 2022-04-04 2023-10-12 Swiftpharma Bv Recombinant spider silk-reinforced collagen proteins produced in plants and the use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5045449A (en) * 1989-06-14 1991-09-03 Thomas Jefferson University Methods of detecting a genetic predisposition for vascular aneurysms
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
DE69230502T2 (de) 2000-08-10
GR3033022T3 (en) 2000-08-31
US5405757A (en) 1995-04-11
DE69230502D1 (de) 2000-02-03
HK1010334A1 (en) 1999-06-17
EP0625048A4 (de) 1995-04-05
DE69230502T3 (de) 2006-05-24
WO1993007889A1 (en) 1993-04-29
EP0962529A1 (de) 1999-12-08
EP0625048B1 (de) 1999-12-29
JPH07501939A (ja) 1995-03-02
AU3055592A (en) 1993-05-21
EP0625048A1 (de) 1994-11-23
EP0625048B2 (de) 2005-10-26
AU4441497A (en) 1998-02-12
DK0625048T4 (da) 2006-02-20
CA2121698A1 (en) 1993-04-29
ES2143478T3 (es) 2000-05-16
JP3302017B2 (ja) 2002-07-15
AU680606B2 (en) 1997-08-07
DK0625048T3 (da) 2000-05-29
CA2121698C (en) 2010-05-18
ES2143478T5 (es) 2006-05-16
JP2002255999A (ja) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE188253T1 (de) Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
EP0846262A4 (de) Abbildung von spektroskopie von gewebe und anderen stark streuenden medien, basierend auf fluoreszenz lebensdauer
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
ES2172502T3 (es) Receptores tipo ii de interleucina 1.
DE69434875D1 (de) BMP-11 Zusammenstellungen
DE69014162D1 (de) Morphogenetisches Knochenprotein.
EA200200755A1 (ru) Опосредованная рецептором nogo блокада роста аксонов
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
ATE342911T1 (de) Synthese von nukleosiden und polynukleotiden
ATE179211T1 (de) Menschliche il-3-varianten
PT1011723E (pt) Factor de crescimento tumorigenico de 88 kda e antagonistas
ATE184917T1 (de) Rekombinante methode und wirt zur herstellung von xylitol
DE60036297D1 (de) Bedingtes 'gene trapping'-konstrukt zur unterbrechung von genen
DE69626981D1 (de) N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
ATE259652T1 (de) Neuronale verwendungen des bmp-11
BR0014183A (pt) Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
ATE233553T1 (de) Mono-und disulfosubstituierte anthrachinone und deren verwendung zur behandlung von knochenmatrixerkrankungen
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE222901T1 (de) Carboxylsubstituierte chromanderivate zur verwendung als beta 3 adrenorezeptor-agonisten
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0625048

Country of ref document: EP